Access to hepatitis C treatment for patients in drug substitution programmes: the fight is far from over

Negro, Francesco; Maistat, Liudmyla

doi:10.4414/smw.2017.14570

Scientific article

English

Access to hepatitis C treatment for patients in drug substitution programmes: the fight is far from over

ContributorsNegro, Francesco; Maistat, Liudmyla

Published inSwiss Medical Weekly, vol. 147, w14570

Publication date2017

Affiliation entities

Faculté de médecine / Section de médecine fondamentale / Département de pathologie et immunologie
Faculté de médecine / Section de médecine clinique / Département de médecine

Research groups

Etudes et traitement de l'hépatite C et B (554)

Citation (ISO format)

NEGRO, Francesco, MAISTAT, Liudmyla. Access to hepatitis C treatment for patients in drug substitution programmes: the fight is far from over. In: Swiss Medical Weekly, 2017, vol. 147, p. w14570. doi: 10.4414/smw.2017.14570

Article (Published version)

CC BY-NC-ND

Identifiers

PID : unige:106628
DOI : 10.4414/smw.2017.14570
PMID : 29231233

Journal ISSN1424-7860

432views

209downloads

Creation12/06/2018 15:30:00

First validation12/06/2018 15:30:00

Update15/03/2023 08:26:50

Status update15/03/2023 08:26:50

Last indexation31/10/2024 10:44:06

Archive ouverte UNIGE

Access to hepatitis C treatment for patients in drug substitution programmes: the fight is far from over

Technical informations